Replies to post #418087 on Anavex Life Sciences Corp (AVXL)

[falconer66a]

The Experts Will Say "Nope!"

Pursuing peer review is a good strategy even if it's frustrating to lose some control over timeliness. Ultimately, it will silence the skeptics....

Nope, just watch.

When a peer-reviewed paper appears in a reputable journal, validating Anavex science (safety and efficacy of blarcamesine), a few of the "real experts" who post so helpfully on this message board will come right out and inform us that the authors and the journal were plainly wrong.

Same thing when the FDA subsequently approves blarcamesine for therapeutic uses. The people who "really know" are here. Real expertise can't be challenged.

[LBSR TO DA MOON]

C'mon Gator328, you can't tease us with that and not give us his name!

I grew up with an undersized kid who was always a very good athlete, the best in the neighborhood. Typical big fish in a small pond story. When he signed with a D1 program on an athletic scholarship, a few of us discounted his odds for success because of his size. It wasn't until he turned pro that we had to admit we were wrong.

[jav0033]

Wrong. Peer reviews bring no appreciation in stock price. Most scientists get paid for biased opinions.